Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Silvia Lampis
Observed names:
Lampis, Silvia,
S. Lampis
Institutions:
Bambino Gesù Children's Hospital,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Bambino Gesù Children's Hospital,
Associazione Italiana Arbitri,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0002-2923-0518
Observed ORCID:
0000-0002-2923-0518
OpenAlex ID:
A5019167752
Works
22
Awards
1
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
2022
·
Damiano Bartolucci
, Luca Montemurro
, et al.
·
Cancers
·
73
PDF
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma
2021
·
Salvatore Raieli
, Daniele Di Renzo
, et al.
·
Frontiers in Oncology
·
49
PDF
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
2019
·
Luca Montemurro
, Salvatore Raieli
, et al.
·
Cancer Research
·
39
PDF
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
2022
·
Silvia Lampis
, Salvatore Raieli
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
29
PDF
Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma
2023
·
Angela Galardi
, Alexander De Bethlen
, et al.
·
Life
·
25
PDF
Organoids as a new approach for improving pediatric cancer research
2024
·
Silvia Lampis
, Angela Galardi
, et al.
·
Frontiers in Oncology
·
16
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance
2023
·
Sonia Bortolotti
, Silvia Angelucci
, et al.
·
Cancers
·
8
PDF
Plasma-derived extracellular vesicles miR-335–5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma
2024
·
Virginia Di Paolo
, Alessandro Paolini
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
6
PDF
Identification of a miRNAs signature as potential biomarker of mesenchymal phenotype in neuroblastoma patients
2025
·
Silvia Lampis
, Alessandro Paolini
, et al.
·
Biomarker Research
·
4
PDF
Toward a role for the acoustic field in cells interaction
2025
·
Marco Girasole
, Pier Francesco Moretti
, et al.
·
Frontiers in Systems Neuroscience
·
1
PDF
Establishment and characterization of primary retinoblastoma cell lines: a comprehensive molecular profiling approach
2026
·
Angela Galardi
, Silvia Lampis
, et al.
·
npj Precision Oncology
PDF
Molecular profiling of high-risk neuroblastoma: clinical and therapeutic implications
2026
·
S. Lampis
, A. Stracuzzi
, et al.
·
EJC Paediatric Oncology
PDF
Identification of a microRNA signature as a potential biomarker of the mesenchymal phenotype in Neuroblastoma
2026
·
S. Lampis
, A. Paolini
, et al.
·
EJC Paediatric Oncology
PDF
Show more works
View as search
Works count:
22
Citation count:
250
H-index:
7
I10-index:
6
Year
Topic
Type